Session Information
AABB SAMs Courses 2012
Click here to go to the previous page
Infusion Practices in Cellular Therapy: Current Practice and Future Direction
Track
:
Sessions
Program Code:
9309-TC-CT
Date:
Monday, October 8, 2012
Time:
10:30 AM to 12:00 PM
EST
Location:
205A
SPEAKER
(S):
Olive Sturtevant, MHP, MT(ASCP)SBB, SLS, CQA(ASQ), Administrative Director of Connell & O'Reilly Families, Dana Farber Cancer Institute
Karen Snow, (ASCP)BB, CQA(ASQ), Quality Manager, Bone Marrow Transplant Program, Massachusetts General Hospital
Dr. Michael Linenberger, MD, Medical Director, Apheresis & Cellular Therapy, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Description
Adverse events and reactions related to the infusion of cellular therapy products are varied and oftentimes not attributed to the product. This session will discuss what constitutes an adverse event or reaction related to CT product infusion, how events may be categorized and what steps may be taken to avoid them in the future. Current practices and uniformity of handling such events will be examined.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |